Lonza announces a price increase of USD 0.80 per kilogram for Niacin feed grade and Niacinamide feed grade.
The increase is necessary due to increases in raw material, energy and transportation costs.
The price increase is effective as of 1 June 2011.
The price increase will impact non-contract customers and other customers as their contracts permit.
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Products and services span its customers’ needs from research to final product manufacture. It is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. In addition, Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.
Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange. In 2010, the company had sales of CHF 2.680 billion. Further information can be found at www.lonza.com.
For further Information
Lonza Group Ltd
Life Science Ingredients - Nutrition
Director of Marketing and Sales
Tel +41 61 316 8552
Lonza Group Ltd
Tel +1 201 316 9413
Fax +1 201 696 3533